Sun Pharmaceutical gets USFDA approval for generic version of Plavix

Sun Pharmaceutical Industries has received an approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for its generic version of Plavix, Clopidogrel Tablets USP 75mg.

The generic Clopidogrel Tablets USP 75mg are therapeutic equivalent of Plavix tablets from Sanfoi-Aventis. Clopidogrel Tablets have annual sales of about $6.7 billion in the US.

Earlier in April, the company received an approval from USFDA for its abbreviated new drug application (ANDA) -- generic version of Zyprexa -- Olanzapine Tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg

Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.